Atwood & Palmer Inc Amgen Inc Transaction History

Atwood & Palmer Inc

$1.45 Billion
Q3 2024

A detailed history of Atwood & Palmer Inc transactions in Amgen Inc stock. As of the latest transaction made, Atwood & Palmer Inc holds 6,206 shares of AMGN stock, worth $1.64 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

6,206

Previous 6,210 0.06%

Holding current value

$1.64 Million

Previous $1.94 Million 3.04%

% of portfolio

0.14%

Previous 0.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $1,237 - $1,349	-4 Reduced 0.06%	6,206 $2 Million
Q2 2024 Jul 10, 2024	BUY	$262.75 - $319.31 $12,349 - $15,007	47 Added 0.76%	6,210 $1.94 Million
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $8,949 - $10,096	-35 Reduced 0.56%	6,163 $1.78 Million
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $18.1 Million - $21.4 Million	-84,419 Reduced 93.16%	6,198 $1.38 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $107,250 - $130,720	475 Added 0.53%	90,617 $21.9 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $300,029 - $381,223	1,310 Added 1.47%	90,142 $23.7 Million
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $222,215 - $250,618	990 Added 1.13%	88,832 $20 Million
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $5.34 Million - $5.95 Million	23,161 Added 35.81%	87,842 $21.4 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $509,802 - $563,975	2,325 Added 3.73%	64,681 $15.6 Million
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $687,329 - $786,585	3,456 Added 5.87%	62,356 $14 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $224,157 - $262,627	1,056 Added 1.83%	58,900 $12.5 Million
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $802,347 - $890,145	3,435 Added 6.31%	57,844 $14.1 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $200,606 - $233,774	904 Added 1.69%	54,409 $13.5 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $717,516 - $854,433	3,316 Added 6.61%	53,505 $12.3 Million
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $296,832 - $330,101	1,265 Added 2.59%	50,189 $12.8 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $72,200 - $88,600	365 Added 0.75%	48,924 $11.5 Million
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $7.05 Million - $9.36 Million	38,706 Added 392.83%	48,559 $9.84 Million
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $241,714 - $283,344	-1,450 Reduced 12.83%	9,853 $1.82 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $51,547 - $58,105	-285 Reduced 2.46%	11,303 $2.15 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $65,116 - $76,011	-365 Reduced 3.05%	11,588 $2.26 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $37,613 - $42,404	-203 Reduced 1.67%	11,953 $2.48 Million
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $37,361 - $41,964	-225 Reduced 1.82%	12,156 $2.24 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $202,548 - $226,308	1,200 Added 10.73%	12,381 $2.15 Million
Q2 2017 Aug 08, 2017	BUY	N/A	11,181	11,181 $1.93 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Account

Atwood & Palmer Inc Amgen Inc Transaction History